Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infants

British Medical Journal

Volumn 312, Issue 7034, 1996, Pages 817-818

  Goldblatt, David ^a   Fairley, Christopher K ^b   Cartwright, Keith ^c   Miller, Elizabeth ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY TITER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FORMULATION; GRAM NEGATIVE INFECTION; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; SYMPTOM;

EID: 0029926681     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7034.817     Document Type: Short Survey

References (5)

1. Booy R, Hodgson S, Carpenter L, Mayon White RT, Slack MP, Macfarlane JA, et al. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T, Lancet 1994;344:362-6.
2. Department of Health. Immunisation against infectious disease. London: HMSO, 1992;100-4.
3. Booy R, Taylor SA, Dobson SRM, Isaacs D, Sleight G, Aitken S, et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child 1992;67:475-8.
4. Käyhty H, Paltola H, Karanko V, Mäkelä P. The protective level of serum antibodies to capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100-3.
5. Granoff DM, Anderson EL, Osterholm MT, Holmes SJ, McHugh JE, Belshe RB, et al. Differences in the immunogenicity of three Haemophilus influenzae type b vaccines in infants. J Pediatr 1992;121:187-94.